260 related articles for article (PubMed ID: 31597225)
1. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225
[TBL] [Abstract][Full Text] [Related]
2. The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis.
Lee JU; Chang HS; Shim EY; Park JS; Koh ES; Shin HK; Park JS; Park CS
Respir Med; 2020 Sep; 171():105945. PubMed ID: 32755764
[TBL] [Abstract][Full Text] [Related]
3. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
[TBL] [Abstract][Full Text] [Related]
4. Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.
Xia H; Gilbertsen A; Herrera J; Racila E; Smith K; Peterson M; Griffin T; Benyumov A; Yang L; Bitterman PB; Henke CA
J Clin Invest; 2017 Jun; 127(7):2586-2597. PubMed ID: 28530639
[TBL] [Abstract][Full Text] [Related]
5. S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis.
Zhang W; Ohno S; Steer B; Klee S; Staab-Weijnitz CA; Wagner D; Lehmann M; Stoeger T; Königshoff M; Adler H
Front Immunol; 2018; 9():1216. PubMed ID: 29910813
[TBL] [Abstract][Full Text] [Related]
6. S100A4
Li Y; Bao J; Bian Y; Erben U; Wang P; Song K; Liu S; Li Z; Gao Z; Qin Z
Front Immunol; 2018; 9():1776. PubMed ID: 30127784
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
8. The function of S100A4 in pulmonary disease: A review.
Wang T
Medicine (Baltimore); 2023 Apr; 102(14):e33466. PubMed ID: 37026957
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan/CD44 axis regulates S100A4-mediated mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.
Xia H; Herrera J; Smith K; Yang L; Gilbertsen A; Benyumov A; Racila E; Bitterman PB; Henke CA
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L926-L941. PubMed ID: 33719561
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis.
Southern BD; Li H; Mao H; Crish JF; Grove LM; Scheraga RG; Mansoor S; Reinhardt A; Abraham S; Deshpande G; Loui A; Ivanov AI; Rosenfeld SS; Bresnick AR; Olman MA
J Biol Chem; 2024 Jan; 300(1):105530. PubMed ID: 38072048
[TBL] [Abstract][Full Text] [Related]
11. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
[TBL] [Abstract][Full Text] [Related]
12. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
[TBL] [Abstract][Full Text] [Related]
13. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
[TBL] [Abstract][Full Text] [Related]
16. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
[TBL] [Abstract][Full Text] [Related]
17. The significance of serum S100 calcium-binding protein A4 in silicosis.
Zhang J; Yuan C; Li E; Guo Y; Cui J; Liu H; Hao X; Guo L
BMC Pulm Med; 2022 Apr; 22(1):127. PubMed ID: 35379204
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
Pandit KV; Corcoran D; Yousef H; Yarlagadda M; Tzouvelekis A; Gibson KF; Konishi K; Yousem SA; Singh M; Handley D; Richards T; Selman M; Watkins SC; Pardo A; Ben-Yehudah A; Bouros D; Eickelberg O; Ray P; Benos PV; Kaminski N
Am J Respir Crit Care Med; 2010 Jul; 182(2):220-9. PubMed ID: 20395557
[TBL] [Abstract][Full Text] [Related]
19. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
20. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
